Fintel on MSN4d
Evercore ISI Group Initiates Coverage of Summit Therapeutics (SMMT) with Outperform RecommendationFintel reports that on March 12, 2025, Evercore ISI Group initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Outperform recommendation. Analyst Price Forecast Suggests 90.91% Upside As ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback